In animal models of conditions such as depression [88], Parkinson’s disease [18], and attention-deficit/hyperactivity disorder [89], LITUS has been demonstrated to increase BDNF levels in multiple brain areas, suggesting its potential in modulating neurotrophic support, thereby induce analgesic effect. This evidence concerns the gene BDNF and Parkinson disease.